# SITAGLIPTIN PHOSPHATE
> **ANDA202473** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2012-10-10
## Drug
- **FDA Application Number:** ANDA202473
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN PHOSPHATE
- **Generic name:** Sitagliptin Phosphate
- **Active ingredients:** SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMS INC
- **First approval:** 2012-10-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202473)
---
*AI Analytics · CC0 1.0*